Teva Pharmaceutical Industries

Teva Pharmaceutical Industries Newswire

Comprehensive Real-Time News Feed for Teva Pharmaceutical Industries.

Results 1 - 20 of 16,392 in Teva Pharmaceutical Industries

  1. Teva offers to buy Mylan in $40.1B cash-and-stock dealRead the original story w/Photo

    17 min ago | KIII

    Generic drug giant Teva formally offered to buy fellow drugmaker Mylan about $40.1 billion in cash and stock on Tuesday, despite Mylan's cold shoulder and the certainty the proposed acquisition will bring intense scrutiny by antitrust regulators. If Israel-based Teva Pharmaceutical Industries Ltd. succeeded, the combination would dominate the global generic drug market, be a major contender in some other specialty drug categories - and have the leverage to try to raise generic drugs prices.

    Comment?

  2. Teva offers to buy Mylan in $40.1B cash-and-stock dealRead the original story

    18 min ago | KIRO-TV Seattle

    Generic drug giant Teva formally offered to buy fellow drugmaker Mylan about $40.1 billion in cash and stock on Tuesday, despite Mylan's cold shoulder and the certainty the proposed acquisition will bring intense scrutiny by antitrust regulators. If Israel-based Teva Pharmaceutical Industries Ltd. succeeded, the combination would dominate the global generic drug market, be a major contender in some other specialty drug categories - and have the leverage to try to raise generic drugs prices.

    Comment?

  3. Avoid Mylan And Perrigo As One Of Their Respective Buyout Offers Will ...Read the original story w/Photo

    21 min ago | Seeking Alpha

    This news comes less than two weeks after Mylan announced its proposal to buy fellow generic drug maker, Perrigo in a deal valued at around $30 billion. Only one of these two offers can reasonably be expected to come to fruition and the firm that is excluded could face the disappearance of its deal premium.

    Comment?

  4. Teva Bids $40 Billion For Mylan, But May Need MoreRead the original story w/Photo

    55 min ago | Investor's Business Daily

    Both stocks rose on the news . to the tune of $29 billion, which some observers said was done at least partly to fend off a Teva bid.

    Comment?

  5. Stocks Mixed, But Palo Alto Hits High On Analyst NodRead the original story w/Photo

    56 min ago | Investor's Business Daily

    The Nasdaq rose 0.4%, but the Dow lost 0.4% and the S&P 500 gave up 0.2%. Volume was tracking higher on both exchanges in the stock market today .

    Comment?

  6. U.S. Stocks Fall on Mixed EarningsRead the original story w/Photo

    1 hr ago | Wall Street Journal

    ... rise as prices fall. In other corporate news, shares of Mylan NV surged 9.9% after rival Teva Pharmaceutical Industries Ltd. proposed to acquire the company for about $40 billion in cash and stock, a tie-up that would create the world's biggest ...

    Comment?

  7. Teva Makes $40 Billion Unsolicited Takeover Bid for MylanRead the original story

    1 hr ago | The Washington Post

    Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world. Teva Pharmaceutical Industries Ltd. made an unsolicited offer to buy Mylan NV for about $40.1 billion, in the drug industry's largest takeover attempt this year.

    Comment?

  8. Deals of the day- Mergers and acquisitionsRead the original story

    1 hr ago | Reuters

    ** Generic drugmaker Teva Pharmaceutical Industries Ltd said that it had proposed buying rival Mylan for $82.00 per share in a mix of stock and cash. ** Hedge fund manager David Einhorn's Greenlight Capital has taken a new stake in General Motors Co, nearly a year after selling off its position in the automaker, the firm said in a letter to clients on Monday seen by Reuters.

    Comment?

  9. At midday: TSX slides as resource shares drop, profit-taking hits railwaysRead the original story w/Photo

    2 hrs ago | The Globe and Mail

    ... offer while investors scrutinized corporate earnings. Biotechnology shares rallied as Teva Pharmaceutical Industries Ltd. proposed to buy Mylan for about $40.1-billion (U.S.). Lam Research Corp. jumped 8.5 per cent, leading gains among ...

    Comment?

  10. Teva makes $40 billion offer for rival MylanRead the original story w/Photo

    2 hrs ago | RTE.ie

    Generic drugmaker Teva Pharmaceutical Industries has proposed buying smaller rival Mylan for $40 billion, saying it was a better deal than Mylan's alternate offer to buy Perrigo. The offer comes after weeks of speculation that Teva, the world's largest generic company, would make a bid for Mylan.

    Comment?

  11. Generic Drugmaker Teva Makes $40 Billion Offer For Rival MylanRead the original story w/Photo

    2 hrs ago | Medical Daily

    Generic drugmaker Teva Pharmaceutical Industries Ltd. on Tuesday proposed buying smaller rival Mylan for $40 billion, saying it was a better deal than Mylan's alternate offer to buy Perrigo Co. The offer comes after weeks of speculation that Teva, the world's largest generic company, would make a bid for Mylan.

    Comment?

  12. Teva offers to buy Mylan in $40 billion dealRead the original story w/Photo

    2 hrs ago | The Times of Israel

    ... Pennsylvania-based Mylan "says it makes about one of every 11 drugs prescribed to Americans." Teva Pharmaceutical Industries Ltd., an Israeli company headquartered in Petah Tikva, has grown to become the world's largest producer of generic ...

    Comment?

  13. UPDATE 3-Generic drugmaker Teva makes $40 billion offer for rival MylanRead the original story

    2 hrs ago | Reuters

    Generic drugmaker Teva Pharmaceutical Industries Ltd. on Tuesday proposed buying smaller rival Mylan for $40 billion, saying it was a better deal than Mylan's alternate offer to buy Perrigo Co . The offer comes after weeks of speculation that Teva, the world's largest generic company, would make a bid for Mylan.

    Comment?

  14. Us Stocks-Wall St edges up as results ease anxiety over earningsRead the original story

    3 hrs ago | Reuters

    U.S. stocks edged up on Tuesday for the second straight day as a spate of companies beat lowered earnings expectations, helping to ease fears of a disappointing quarter. A majority of the top 10 S&P 500 sectors were up, with the health index leading the gains following Teva Pharmaceutical's bid for Mylan.

    Comment?

  15. UPDATE 2-Generic drugmaker Teva makes $40 billion offer for rival MylanRead the original story

    3 hrs ago | Reuters

    Generic drugmaker Teva Pharmaceutical Industries Ltd. on Tuesday proposed buying Mylan for $40 billion, saying it was a better deal than the smaller rival's offer to buy Perrigo Co. The bid comes after weeks of speculation that Teva, the world's largest generic company, would make a bid for Mylan.

    Comment?

  16. Generics Maker Teva Offers $82/Share for MylanRead the original story w/Photo

    3 hrs ago | Fox News

    Teva Pharmaceutical Industries Ltd. has proposed to acquire generic-drug rival Mylan NV for about $40 billion in cash and stock. A Mylan spokesman couldn't immediately be reached to comment.

    Comment?

  17. Mylan (MYL) Stock Surging Today on Takeover Offer From TevaRead the original story w/Photo

    3 hrs ago | TheStreet.com

    Although Mylan has yet to issue a statement about the offer, when reports started circulating last week that a takeover from Teva was possible the company issued a statement on April 17 regarding the speculation saying: "Mylan is fully committed to its stand-alone strategy, including its proposal to acquire Perrigo , and today's speculation has no impact whatsoever on this strategy." Separately, TheStreet Ratings team rates MYLAN NV as a Buy with a ratings score of B+.

    Comment?

  18. Teva Pharmaceuticals working on billon dollar bid to take over MylanRead the original story w/Photo

    4 hrs ago | Jerusalem Post

    Bloomberg reports that Teva Pharmaceutical Industries Ltd. could publish a bid for its US rival Mylan Inc. today, in what could turn out to be the largest deal of the year in pharmaceuticals. Citing sources familiar with the matter, Bloomberg says that Teva is working with Barclays Bank on a takeover bid for Mylan, which has a current market cap of $33.3 billion, and is in touch with other banks on finance for such a deal.

    Comment?

  19. The Wall Street Journal: Teva offers to buy Mylan for $40 billionRead the original story w/Photo

    4 hrs ago | MarketWatch

    Teva Pharmaceutical Industries Ltd. has proposed to acquire rival Mylan N.V. for about $40 billion in cash and stock, a tie-up that would create the world's biggest generic drug company by sales. spokesman couldn't immediately be reached to comment.

    Comment?

  20. US open: Stocks edge forward on upbeat earningsRead the original story

    3 hrs ago | Live Charts

    US stocks edged higher on Tuesday, as markets were buoyed by a raft of better-than-expected earnings. Just before 15:00 the Dow Jones Industrial Average was up 12 points, while the S&P 500 and the Nasdaq gained four and 23 points respectively.

    Comment?